LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 511

Search options

  1. Article ; Online: Social norm compliance and involvement with Covid-19

    Roger Mason / Karen M. Corbishley / Thomas Dobbelstein

    International Journal of Research In Business and Social Science, Vol 11, Iss 5, Pp 406-

    2022  Volume 422

    Abstract: Consumer decisions are influenced by various variables, including compliance with society’s social norms and by involvement by consumers with the issue under consideration. Both variables have influenced consumers’ actions during previous pandemics. ... ...

    Abstract Consumer decisions are influenced by various variables, including compliance with society’s social norms and by involvement by consumers with the issue under consideration. Both variables have influenced consumers’ actions during previous pandemics. Therefore, this study investigated involvement with the Covid-19 pandemic, together with social norm compliance (SNC), their mutual influence, and how demographic characteristics and country of residence influenced these three issues. The methodology involved a quantitative descriptive cross-sectional survey, with a quota sample of 1096 responses, based on age, gender, education, habitation, and income. The research was conducted with populations representing the consumers who patronize major retailers in a developed country (Germany) and a developing one (South Africa). Data was collected via questionnaires e-mailed to commercial consumer panels covering both countries. The findings showed that involvement is influenced by gender, age, education, habitation, and country of residence, but that SNC is not influenced by demographics but does differ according to country. Further findings were that involvement with Covid-19 strongly influences SNC and, similarly, SNC also strongly influences involvement with Covid-19. Furthermore demographics, excluding habitation, also influence these variables. However, the relationship between the involvement and SNC variables does not differ between the two countries. This study has provided a better understanding of consumers’ involvement with Covid-19 and SNC as components of consumer behavior, which is important since, during the Covid-19 pandemic, retailers have been instrumental in implementing health protocols. Therefore, understanding the relationship between involvement with Covid-19 and SNC, and how they are influenced by consumer demographics, is important.
    Keywords covid-19 ; pandemic ; demographics ; involvement ; social norms ; consumer decisions ; social norm compliance ; Social Sciences ; H
    Subject code 300
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher Center for Strategic Studies in Business & Finance
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Internal vascular channel architecture in human auditory ossicles.

    Manoharan, Shivani M / Gray, Roger / Hamilton, John / Mason, Matthew J

    Journal of anatomy

    2022  Volume 241, Issue 2, Page(s) 245–258

    Abstract: The vascular supply of the human auditory ossicles has long been of anatomical and clinical interest. While the external blood supply has been well-described, there is only limited information available regarding the internal vascular architecture of the ...

    Abstract The vascular supply of the human auditory ossicles has long been of anatomical and clinical interest. While the external blood supply has been well-described, there is only limited information available regarding the internal vascular architecture of the ossicles, and there has been little comparison of this between individuals. Based on high-resolution micro-CT scans, we made reconstructions of the internal vascular channels and cavities in 12 sets of ossicles from elderly donors. Despite considerable individual variation, a common basic pattern was identified. The presence of channels within the stapes footplate was confirmed. The long process of the incus and neck of the stapes showed signs of bony erosion in all specimens examined. More severe erosion was associated with interruption of some or all of the main internal vascular channels which normally pass down the incudal long process; internal excavation of the proximal process could interrupt vascular channels in ossicles which did not appear to be badly damaged from exterior inspection. An awareness of this possibility may be helpful for surgical procedures that compromise the mucosal blood supply. We also calculated ossicular densities, finding that the malleus tends to be denser than the incus. This is mainly due to a lower proportion of vascular channels and cavities within the malleus.
    MeSH term(s) Aged ; Ear Ossicles ; Ear, Middle ; Humans ; Incus ; Malleus ; Tomography, X-Ray Computed
    Language English
    Publishing date 2022-03-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 2955-5
    ISSN 1469-7580 ; 0021-8782
    ISSN (online) 1469-7580
    ISSN 0021-8782
    DOI 10.1111/joa.13661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Effect of Daily Heart Rate Workloads on Preseason, Midseason, and Postseason Oxygen Consumption in Division I Basketball.

    Howard, Mason / Sanders, Gabriel J / Kollock, Roger O / Peacock, Corey A / Freire, Raul

    Journal of strength and conditioning research

    2023  Volume 38, Issue 4, Page(s) 704–708

    Abstract: Abstract: Howard, M, Sanders, GJ, Kollock, RO, Peacock, CA, and Freire, R. The effect of daily ...

    Abstract Abstract: Howard, M, Sanders, GJ, Kollock, RO, Peacock, CA, and Freire, R. The effect of daily heart rate workloads on preseason, midseason, and postseason oxygen consumption in Division I basketball. J Strength Cond Res 38(4): 704-708, 2024-Basketball is a dynamic sport, requiring athletes to elicit a high-level of physical, tactical, technical, and psychological attributes and athletes must possess a robustly trained aerobic energy system. There is no research to assess how objectively measured training loads throughout a season influence aerobic capacity. The following study was a retrospective analysis of an NCAA Division I women's basketball team throughout a 5-month (23-week) competitive season. Data were sorted into season half totals and maximal oxygen consumption was recorded before, at the midway point and within 1-week postseason. Twelve athletes were monitored during each practice, pregame shoot around, scrimmage, and game for a total of 1,378 recorded sessions with a valid heart rate-based wearable microsensor (Polar Team Pro) during the season. There was a main effect of time for V̇O 2max throughout the season ( p < 0.001). Post hoc analysis revealed there was a significant increase in V̇O 2max from preseason to postseason ( p < 0.001). Interestingly, there were significant ( p ≤ 0.001 for all) decreases from the first half to the second half of the season for training load, and time allocated to HR Zone1-4 , but no difference in time for the most intense zone, HR zone5 . Conclusion: Oxygen consumption significantly increased 7.5% from preseason to postseason despite a reduction in overall work. The only training intensity that was not different from the first half to second half of the season was time in the highest heart rate intensity zone ≥85% of HR max .
    MeSH term(s) Humans ; Female ; Basketball/physiology ; Workload ; Heart Rate/physiology ; Retrospective Studies ; Oxygen Consumption/physiology ; Athletes
    Language English
    Publishing date 2023-12-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1156349-7
    ISSN 1533-4287 ; 1064-8011
    ISSN (online) 1533-4287
    ISSN 1064-8011
    DOI 10.1519/JSC.0000000000004692
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

    Mason, Roger M

    International journal of experimental pathology

    2012  Volume 94, Issue 1, Page(s) 1–16

    Abstract: ... hepatocyte growth factor, CCN3 and Oncostatin M, are discussed. These may determine whether injured tissue heals or ...

    Abstract Connective tissue growth factor (CTGF, CCN2) is a member of the CCN family of matricellular proteins. It interacts with many other proteins, including plasma membrane proteins, modulating cell function. It is expressed at low levels in normal adult kidney cells but is increased in kidney diseases, playing important roles in inflammation and in the development of glomerular and interstitial fibrosis in chronic disease. This review reports the evidence for its expression in human and animal models of chronic kidney disease and summarizes data showing that anti-CTGF therapy can successfully attenuate fibrotic changes in several such models, suggesting that therapies targeting CTGF and events downstream of it in renal cells may be useful for the treatment of human kidney fibrosis. Connective tissue growth factor stimulates the development of fibrosis in the kidney in many ways including activating cells to increase extracellular matrix synthesis, inducing cell cycle arrest and hypertrophy, and prolonging survival of activated cells. The relationship between CTGF and the pro-fibrotic factor TGFβ is examined and mechanisms by which CTGF promotes signalling by the latter are discussed. No specific cellular receptors for CTGF have been discovered but it interacts with and activates several plasma membrane proteins including low-density lipoprotein receptor-related protein (LRP)-1, LRP-6, tropomyosin-related kinase A, integrins and heparan sulphate proteoglycans. Intracellular signalling and downstream events triggered by such interactions are reviewed. Finally, the relationships between CTGF and several anti-fibrotic factors, such as bone morphogenetic factor-4 (BMP4), BMP7, hepatocyte growth factor, CCN3 and Oncostatin M, are discussed. These may determine whether injured tissue heals or progresses to fibrosis.
    MeSH term(s) Animals ; Connective Tissue Growth Factor/genetics ; Connective Tissue Growth Factor/metabolism ; Cytokines/metabolism ; Disease Progression ; Fibrosis ; Humans ; Inflammation Mediators/metabolism ; Kidney/metabolism ; Kidney/pathology ; Kidney Diseases/genetics ; Kidney Diseases/metabolism ; Kidney Diseases/pathology ; Kidney Diseases/therapy ; Prognosis ; Signal Transduction ; Transforming Growth Factor beta/metabolism
    Chemical Substances CCN2 protein, human ; Cytokines ; Inflammation Mediators ; Transforming Growth Factor beta ; Connective Tissue Growth Factor (139568-91-5)
    Language English
    Publishing date 2012-10-30
    Publishing country England
    Document type Address ; Research Support, Non-U.S. Gov't
    ZDB-ID 1016006-1
    ISSN 1365-2613 ; 0958-4625 ; 0007-1021 ; 0959-9673
    ISSN (online) 1365-2613
    ISSN 0958-4625 ; 0007-1021 ; 0959-9673
    DOI 10.1111/j.1365-2613.2012.00845.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

    Mason, Roger M

    Journal of cell communication and signaling

    2009  Volume 3, Issue 2, Page(s) 95–104

    Abstract: Connective tissue growth factor (CTGF/CCN2) is a member of the CCN family of matricellular proteins. Its expression is induced by a number of factors including TGF-beta. It has been associated with fibrosis in various tissues including the kidney. ... ...

    Abstract Connective tissue growth factor (CTGF/CCN2) is a member of the CCN family of matricellular proteins. Its expression is induced by a number of factors including TGF-beta. It has been associated with fibrosis in various tissues including the kidney. Diabetic nephropathy (DN) develops in about 30% of patients with diabetes and is characterized by thickening of renal basement membranes, fibrosis in the glomerulus (glomerulosclerosis), tubular atrophy and interstitial fibrosis, all of which compromise kidney function. This review examines changes in CTGF expression in the kidney in DN, the effects they have on glomerular mesangial and podocyte cells and the tubulointerstitium, and how these contribute to driving fibrotic changes in the disease. CTGF can bind to several other growth factors modifying their function. CTGF is also able to interact with receptors on cells, including integrins, tyrosine receptor kinase A (TrkA), low density lipoprotein receptor-related protein (LRP) and heparan sulphate proteoglycans. These interactions, the intracellular signalling pathways they activate, and the cellular responses evoked are reviewed. CTGF also induces the expression of chemokines which themselves have pharmacological actions on cells. CTGF may prompt some responses by acting through several different mechanisms, possibly simultaneously. For example, CTGF is often described as an effector of TGF-beta. It can promote TGF-beta signalling by binding directly to the growth factor, promoting its interaction with the TGF-beta receptor; by triggering intracellular signalling on binding the TrkA receptor, which leads to the transcriptional repression of Smad7, an inhibitor of the TGF-beta signalling pathway; and by binding to BMP-7 whose own signalling pathway opposing TGF-beta is inhibited, leading to enhanced TGF-beta signalling.
    Language English
    Publishing date 2009-02-14
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2299380-0
    ISSN 1873-961X ; 1873-9601
    ISSN (online) 1873-961X
    ISSN 1873-9601
    DOI 10.1007/s12079-009-0038-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Problems with Social Cognition and Decision-Making in Huntington's Disease: Why Is it Important?

    Mason, Sarah L / Schaepers, Miriam / Barker, Roger A

    Brain sciences

    2021  Volume 11, Issue 7

    Abstract: Huntington's disease starts slowly and progresses over a 15-20 year period. Motor changes begin subtly, often going unnoticed by patients although they are typically visible to those close to them. At this point, it is the early non-motor problems of HD ... ...

    Abstract Huntington's disease starts slowly and progresses over a 15-20 year period. Motor changes begin subtly, often going unnoticed by patients although they are typically visible to those close to them. At this point, it is the early non-motor problems of HD that arguably cause the most functional impairment. Approximately 65% of gene carriers will experience a reduction in their occupational level, and just under half will feel unable to manage their finances independently before a clinical diagnosis is made. Understanding what drives this impairment in activities of daily living is the key to helping people with HD to live more independently for longer, especially in early disease. Early cognitive decline is likely to play a contributory factor although few studies have looked directly at this relationship. Recently, it has been shown that along with the well documented dysexecutive syndrome seen in HD, changes in social cognition and decision-making are more common than previously thought. Furthermore, some of the early neuropathological and neurochemical changes seen in HD disrupt networks known to be involved in social functioning. In this review, we explore how HD changes the way individuals interact in a social world. Specifically, we summarise the literature on both classical and social decision-making (value-based decision-making in a social context) along with studies of theory of mind, empathy, alexithymia, and emotion recognition in HD. The literature specific to HD is discussed and supported by evidence from similar neurodegenerative disorders and healthy individuals to propose future directions and potential therapeutic avenues to be explored.
    Language English
    Publishing date 2021-06-24
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci11070838
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.

    Hagiwara, Akifumi / Schlossman, Jacob / Shabani, Soroush / Raymond, Catalina / Tatekawa, Hiroyuki / Abrey, Lauren E / Garcia, Josep / Chinot, Olivier / Saran, Frank / Nishikawa, Ryo / Henriksson, Roger / Mason, Warren P / Wick, Wolfgang / Cloughesy, Timothy F / Ellingson, Benjamin M

    Journal of neuro-oncology

    2022  Volume 159, Issue 3, Page(s) 509–518

    Abstract: Purpose: Pseudoprogression (PsP) remains an elusive and clinically important, yet ill-defined, phenomena that, generally, involves a period of early radiographic progression (enhancement) followed by a period of radiographic stability or regression. In ... ...

    Abstract Purpose: Pseudoprogression (PsP) remains an elusive and clinically important, yet ill-defined, phenomena that, generally, involves a period of early radiographic progression (enhancement) followed by a period of radiographic stability or regression. In the current study, we utilized data from the control arm of a phase III clinical trial in newly-diagnosed glioblastoma to explore imaging characteristics of "clinically-defined PsP", or early radiographic progression (PFS < 6 months from chemoradiation) followed by a long post-progression residual overall survival (ROS > 12 months).
    Methods: One hundred sixty-nine patients with newly-diagnosed GBM from the control arm of the AVAglio trial (NCT00943826) who presented with early radiographic progressive disease (PD) (< 6 months) were included. Clinical characteristics, topographical patterns, and radiomic features were compared between newly-diagnosed GBM exhibiting early PD and early death (< 12-month ROS, "true PD") with those exhibiting early PD and a long residual survival (> 12-month ROS, "clinically-defined PsP").
    Results: "Clinically-defined PsP" occurred to 38.5% of patients with early PD, and was more associated with MGMT methylation (P = 0.02), younger age (P = 0.003), better neurological performance (P = 0.01), and lower contrast-enhancing tumor volume (P = 0.002) at baseline. GBM showing "true PD" occurred more frequently in the right internal capsule, thalamus, lentiform nucleus, and temporal lobe than those with "clinical PsP". Radiomic analysis predicted "clinical PsP" with > 70% accuracy on the validation dataset.
    Conclusion: Patients with early PD that eventually exhibit "clinically-defined PsP" have distinct clinical, molecular, and MRI characteristics. This information may be useful for treating clinicians to better understand the potential risks and outcome in patients exhibiting early radiographic changes following chemoradiation.
    MeSH term(s) Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/therapy ; Chemoradiotherapy/methods ; Disease Progression ; Glioblastoma/diagnostic imaging ; Glioblastoma/therapy ; Humans ; Incidence ; Magnetic Resonance Imaging ; Reactive Oxygen Species
    Chemical Substances Reactive Oxygen Species
    Language English
    Publishing date 2022-07-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-022-04088-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.

    Anil, Megha / Mason, Sarah L / Barker, Roger A

    Journal of Huntington's disease

    2020  Volume 9, Issue 3, Page(s) 275–282

    Abstract: Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that typically manifests between the ages of 30 and 50 years. However, the disease can present at any age, and phenotypic differences between younger and later- ... ...

    Abstract Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that typically manifests between the ages of 30 and 50 years. However, the disease can present at any age, and phenotypic differences between younger and later-onset patients have received limited attention.
    Objective: To compare clinical features of late- (>70 years of age) and younger-onset (<30 years of age) HD patients.
    Methods: Patients presenting to our regional NHS HD clinic with new-onset manifest HD diagnosed over the age of 70 years (LoHD) (n = 18) were compared with a younger cohort who developed disease under the age of 30 years (YoHD) (n = 12). Rate of progression over time on standard cognitive and motor measures was compared.
    Results: At first clinic presentation, both groups had the same total UHDRS scores. However, the LoHD group had higher chorea scores (F (1,28) = 6.52, p = 0.016), while the YoHD group had more dystonia (F (1,28) = 8.69, p = 0.006) and eye movement abnormalities (F (1,28) = 16.991, p < 0.001). The YoHD group also had a greater rate of motor progression, especially for bulbar measures (F (1, 28) = 6.96, p = 0.013) and bradykinesia (F (1, 28) = 7.99, p = 0.009). No differences were found in the rate of cognitive change (F (1,21) = 1.727, p = 0.203) nor functional capacity (F (1,28) = 1.388, p = 0.249) between the groups.
    Conclusion: Phenotypic differences between YoHD and LoHD patients were found in terms of initial presentation and rate of motor progression. This has implications for therapeutic trials involving HD patients of different ages, given their different clinical features and progression.
    MeSH term(s) Adult ; Age of Onset ; Aged ; Brain Stem/physiopathology ; Cohort Studies ; Disease Progression ; Dystonia/etiology ; Dystonia/physiopathology ; Female ; Functional Status ; Gait Disorders, Neurologic/etiology ; Gait Disorders, Neurologic/physiopathology ; Humans ; Huntington Disease/complications ; Huntington Disease/physiopathology ; Hypokinesia/etiology ; Hypokinesia/physiopathology ; Male ; Ocular Motility Disorders/etiology ; Ocular Motility Disorders/physiopathology ; Phenotype ; Severity of Illness Index ; Speech Disorders/etiology ; Speech Disorders/physiopathology ; Young Adult
    Language English
    Publishing date 2020-07-13
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2673033-9
    ISSN 1879-6400 ; 1879-6397
    ISSN (online) 1879-6400
    ISSN 1879-6397
    DOI 10.3233/JHD-200404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Factors that influence the marketing of professional services

    Enerson, Meg / Corbishley, Karen M / Mason, Roger Burford

    Investment management and financial innovations Vol. 13, No. 3 , p. 118-130

    2016  Volume 13, Issue 3, Page(s) 118–130

    Author's details Meg Enerson, Roger B. Mason, Karen M. Corbishley
    Keywords professional practioners ; professional services ; marketing mix ; 7Ps ; services
    Language English
    Publisher Publishing Company "Business Perspectives"
    Publishing place Sumy
    Document type Article
    Note Zusammenfassung in ukrainischer Sprache
    ZDB-ID 2467221X
    ISSN 1810-4967
    Database ECONomics Information System

    More links

    Kategorien

  10. Article ; Online: Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report.

    Nazarian, Javad / Mason, Gary E / Ho, Cheng Ying / Panditharatna, Eshini / Kambhampati, Madhuri / Vezina, L Gilbert / Packer, Roger J / Hwang, Eugene I

    Oncotarget

    2023  Volume 14, Page(s) 449

    Language English
    Publishing date 2023-05-12
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.28286
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top